Literature DB >> 1382782

Effects of a potassium channel opener (SDZ PCO 400) on guinea-pig and human pulmonary airways.

I D Chapman1, A Kristersson, G Mathelin, E Schaeublin, L Mazzoni, K Boubekeur, N Murphy, J Morley.   

Abstract

1. SDZ PCO 400 evoked dose-related relaxation of isolated airway smooth muscle. For human bronchus precontracted by endogenous tone or addition of carbachol (10(-5) M), IC50 values were 1.74 microM and 1.82 microM respectively. With guinea-pig trachea contracted by endogenous tone, a comparable IC50 (1.79 microM) was observed, but no IC50 (less than 100 microM) could be determined following contraction by carbachol (10(-6) M). 2. Airway obstruction induced by intravenous bombesin in the anaesthetized ventilated guinea-pig was diminished by intravenous injection of SDZ PCO 400 (ID50 54 micrograms kg-1) or by introduction into the duodenum (ID50 1.0 mg kg-1). Inhalation of nebulized SDZ PCO 400 (0.1 mg kg-1) diminished airway obstruction due to intravenous injection of histamine (3.2-5.6 micrograms kg-1) for up to 20 min. 3. Increased bronchoconstrictor responses to bombesin (180-240 ng kg-1) following intravenous infusion of platelet activating factor (PAF) or (+/-)-isoprenaline, or to histamine (1.0-3.2 micrograms kg-1) following intravenous injections of immune complexes, were suppressed following concomitant intravenous infusion of SDZ PCO 400 (ID50 0.3 mg kg-1 h-1, 1.0 mg kg-1 h-1 and 0.1 mg kg-1 h-1 respectively). 4. Intravenous injection of SDZ PCO 400 (0.1 mg kg-1) effected transient (less than 10 min) inhibition of histamine-induced bronchospasm, yet diminished, for prolonged periods [up to 40 min] the enhanced bronchoconstrictor responses to histamine that followed intravenous injections of immune complexes.The capacity of SDZ PCO 400 to resolve such established airway hyperreactivity was prevented by prior intraduodenal instillation of a potassium channel antagonist, glibenclamide (30 mg kg-').5. In sensitized guinea-pigs, SDZ PCO 400 inhaled as a dry powder (5.7 mg kg-') suppressed development of allergic airway hyperreactivity to histamine (1.8-3.2;pg kg-', i.v.), but failed to diminish accumulation of eosinophils or other inflammatory cells within the airway lumen 24 h after inhalation of ovalbumin.6. Preincubation (30 min) of isolated sensitized trachea of guinea-pig with SDZ PCO 400 (10-5-10-4M) did not influence contractile responses to ovalbumin. However in anaesthetized sensitized guinea-pigs,insufflation of SDZ PCO 400 (1.25 mg) as a powder substantially diminished airway obstruction that followed inhalation of ovalbumin. This effect was prevented by prior vagal section.7. It is concluded that SDZ PCO 400 reduces airway obstruction not only through direct actions on airway smooth muscle but also by impairing the expression of airway hyperreactivity, without directly influencing inflammatory events in the airways.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382782      PMCID: PMC1907487          DOI: 10.1111/j.1476-5381.1992.tb14350.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Development of airway hyperreactivity in the guinea-pig following allergic reactions.

Authors:  K Boubekeur; A Kristersson; I D Chapman; J Morley
Journal:  Agents Actions Suppl       Date:  1991

2.  A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways.

Authors:  M Ichinose; P J Barnes
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

3.  Comparison of the effects of RP 49356, cromakalim and nifedipine on guinea-pig trachea in vitro.

Authors:  T J Brown; J Sweetland; D Raeburn
Journal:  Pflugers Arch       Date:  1989       Impact factor: 3.657

4.  The effect of prophylactic anti-asthma drugs on PAF-induced airway hyperreactivity.

Authors:  S Sanjar; D Smith; E Schaeublin; A Kristersson; I Chapman; L Mazzoni; J Morley
Journal:  Jpn J Pharmacol       Date:  1989-10

5.  Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline.

Authors:  S Sanjar; A Kristersson; L Mazzoni; J Morley; E Schaeublin
Journal:  J Physiol       Date:  1990-06       Impact factor: 5.182

6.  Ruthenium red selectively inhibits oedema formation and increased blood flow induced by capsaicin in rabbit skin.

Authors:  T L Buckley; S D Brain; T J Williams
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

7.  Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs.

Authors:  S Sanjar; S Aoki; A Kristersson; D Smith; J Morley
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

8.  The effects of BRL 38227 on antigen-induced extravasation and cellular infiltration into the peritoneal cavity of actively sensitised rats.

Authors:  D R Buckle; J F Taylor
Journal:  Agents Actions Suppl       Date:  1991

9.  Evaluation of the potassium channel activator cromakalim (BRL 34915) as a bronchodilator in the guinea-pig: comparison with nifedipine.

Authors:  J R Arch; D R Buckle; J Bumstead; G D Clarke; J F Taylor; S G Taylor
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

10.  Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.

Authors:  H Nagai; K Kitagaki; S Goto; H Suda; A Koda
Journal:  Jpn J Pharmacol       Date:  1991-05
View more
  7 in total

Review 1.  Anomalous effects of albuterol and other sympathomimetics in the guinea pig.

Authors:  J Morley
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

2.  KATP channel openers reverse immune complex-induced airways hyperreactivity independently of smooth muscle relaxation.

Authors:  K H Buchheit; A Hofmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 3.  Potassium channel openers and asthma.

Authors:  J Morley
Journal:  Clin Rev Allergy       Date:  1994

4.  Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats.

Authors:  N E Bowring; J R Arch; D R Buckle; J F Taylor
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma.

Authors:  N S Cook; I D Chapman
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

6.  A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat.

Authors:  J P Hannon; H J Pfannkuche; J R Fozard
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

7.  Genetic determinants of ammonia-induced acute lung injury in mice.

Authors:  Kiflai Bein; Koustav Ganguly; Timothy M Martin; Vincent J Concel; Kelly A Brant; Y P Peter Di; Swapna Upadhyay; James P Fabisiak; Louis J Vuga; Naftali Kaminski; Emrah Kostem; Eleazar Eskin; Daniel R Prows; Ann-Soo Jang; George D Leikauf
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-10-14       Impact factor: 5.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.